Anti-CD3 monoclonal antibody effect on splenic Foxp3+ regulatory T cells
Summary:
Analysis of sorted spleen T cells of BDC2.5 RAGo/o Foxp3 NOD mice after anti-CD3 treatment. Anti-CD3 treatment prevented diabetes development in BDC2.5.RAGo/o mice. Results provide insight into the mechanism of action of anti-CD3.
Nishio J, Feuerer M, Wong J, Mathis D et al. Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints. J Exp Med 2010 Aug 30;207(9):1879-89. PMID: 20679403